Par Drugs Chemicals Ltd vs Supriya Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Par Drugs & Chemicals Ltd is ₹ 87.29 as of 15 May 15:30 . The P/E Ratio of Par Drugs & Chemicals Ltd changed from 6.6 on March 2021 to 7.8 on March 2025 . This represents a CAGR of 3.40% over 5 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 31.4 on March 2025 . This represents a CAGR of 4.73% over 4 years The Market Cap of Par Drugs & Chemicals Ltd changed from ₹ 76.17 crore on March 2021 to ₹ 104.5 crore on March 2025 . This represents a CAGR of 6.53% over 5 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 5903 crore on March 2025 . This represents a CAGR of 10.45% over 4 years The revenue of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 19.97 crore as compare to the Dec '25 revenue of ₹ 30.67 crore. This represent the decline of -34.89% The revenue of Supriya Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 209.05 crore. This represent the decline of -100% The ebitda of Par Drugs & Chemicals Ltd for the Mar '26 is ₹ 1.8 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the decline of -75.64% The ebitda of Supriya Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 74.24 crore. This represent the decline of -100% The net profit of Par Drugs & Chemicals Ltd changed from ₹ 2.53 crore to ₹ 0.85 crore over 8 quarters. This represents a CAGR of -42.04% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Par Drugs & Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani.
The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business.
With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Par Drugs & Chemicals Ltd or Supriya Lifescience Ltd?

Market cap of Par Drugs & Chemicals Ltd is 107 Cr while Market cap of Supriya Lifescience Ltd is 5,548 Cr

What are the key factors driving the stock performance of Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd?

The stock performance of Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd?

As of May 18, 2026, the Par Drugs & Chemicals Ltd stock price is INR ₹87.29. On the other hand, Supriya Lifescience Ltd stock price is INR ₹689.45.

How do dividend payouts of Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Par Drugs & Chemicals Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.